B. Braun to Showcase its Latest Innovative Echogenic Catheters at ASA
BETHLEHEM, Pa., Oct. 10, 2013 /PRNewswire/ — B. Braun Medical Inc. (B.Braun) will officially launch Contiplex(®) C, its revolutionary, one-step, echogenic catheter-over-needle system and unveil Contiplex Echo, its echogenic, styleted catheter, both designed for Continuous Peripheral Nerve Blocks (CPNB) at the American Society of Anesthesiologists (ASA) annual meeting in San Francisco, California, October 12(th)-14(th). As the market leader in regional anesthesia, B.Braun is committed to providing products and services to meet the changing needs within the acute pain management field.
New CPNB Catheters: Contiplex C & Contiplex Echo
Contiplex C is a novel and innovative catheter-over-needle system for CPNB and practitioners seeking to transition from single shot to continuous techniques. The catheter tip can be purposely directed to an exact location, without the need to thread. Once the catheter tip is in the desired location, the needle is removed in one easy step, and the catheter is already placed. Its catheter-over-needle design helps reduce leakage because the catheter sits tightly within the puncture site. Visit www.contiplexC.com for videos and further information.
Contiplex Echo is a new styleted catheter, featuring flat coil technology to enhance echogenicity. Its rigid body is designed to facilitate controlled threading with the aid of a stylet. Contiplex Echo will be available in both open and closed tip (multi-port) configurations along with the Contiplex Tuohy Ultra needle to provide echogenicity from both needle and catheter during CPNB placement.
Attendees are encouraged to visit B.Braun’s booth #1917 at ASA to experience hands-on demonstrations of these and other exciting regional anesthesia products, infusion pumps, CAPS(®) pre-filled sterile admixtures, and anesthesia IV administration sets from B.Braun. Visit www.bbraunASA.com for videos and further information.
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise(®)” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun Group of Companies in the U.S. includes B.Braun, B. Braun Interventional Systems, Aesculap(®) and CAPS(®). B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.
SOURCE B. Braun Medical Inc.